Total Payments
$247,801
2024 Payments
$23,099
Companies
36
Transactions
500
Medicare Patients
2,605
Medicare Billing
$220,846
Payment Breakdown by Category
Other$228,825 (92.3%)
Food & Beverage$8,140 (3.3%)
Travel$7,832 (3.2%)
Consulting$2,216 (0.9%)
Education$789.08 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $221,925 | 120 | 89.6% |
| Food and Beverage | $8,140 | 340 | 3.3% |
| Travel and Lodging | $7,832 | 20 | 3.2% |
| Honoraria | $6,900 | 4 | 2.8% |
| Consulting Fee | $2,216 | 2 | 0.9% |
| Education | $789.08 | 14 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $104,702 | 170 | $0 (2024) |
| Amgen Inc. | $43,799 | 59 | $0 (2022) |
| Lilly USA, LLC | $31,281 | 41 | $0 (2021) |
| Allergan, Inc. | $26,898 | 25 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $19,596 | 30 | $0 (2020) |
| Lundbeck LLC | $9,739 | 16 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $7,375 | 7 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $1,177 | 2 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $758.90 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $694.90 | 42 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,099 | 48 | ABBVIE INC. ($22,455) |
| 2023 | $33,204 | 74 | ABBVIE INC. ($32,949) |
| 2022 | $41,544 | 61 | ABBVIE INC. ($28,638) |
| 2021 | $54,238 | 56 | AbbVie Inc. ($20,618) |
| 2020 | $40,238 | 57 | Allergan, Inc. ($23,199) |
| 2019 | $20,964 | 90 | Amgen Inc. ($19,872) |
| 2018 | $24,101 | 68 | Amgen Inc. ($13,765) |
| 2017 | $10,414 | 46 | Supernus Pharmaceuticals, Inc. ($9,764) |
All Payment Transactions
500 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $111.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $123.06 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $56.45 | General |
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: Central Nervous System | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: Immunology | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: PAIN | ||||||
| 08/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $104.17 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 436 | 557 | $106,264 | $37,959 |
| 2022 | 14 | 615 | 753 | $149,233 | $54,716 |
| 2021 | 16 | 775 | 929 | $171,037 | $66,784 |
| 2020 | 15 | 779 | 994 | $174,616 | $61,387 |
Total Patients
2,605
Total Services
3,233
Medicare Billing
$220,846
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 103 | 121 | $18,150 | $8,288 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 113 | 138 | $13,524 | $5,668 | 41.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 37 | 37 | $11,877 | $4,373 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 48 | 48 | $11,856 | $4,284 | 36.1% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 13 | 39 | $13,570 | $3,797 | 28.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 16 | 43 | $12,083 | $3,360 | 27.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $9,288 | $3,015 | 32.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 25 | 50 | $5,200 | $1,551 | 29.8% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 16 | 16 | $3,872 | $1,248 | 32.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,132 | $1,159 | 37.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 16 | 16 | $2,048 | $671.52 | 32.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 13 | 13 | $1,664 | $545.61 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 129 | 149 | $22,350 | $9,754 | 43.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 77 | 77 | $24,717 | $9,638 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 70 | 70 | $17,290 | $5,998 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 104 | 125 | $12,250 | $5,442 | 44.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 22 | 55 | $15,455 | $4,377 | 28.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $9,288 | $3,561 | 38.3% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2022 | 13 | 36 | $11,964 | $3,388 | 28.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 45 | 85 | $8,840 | $2,839 | 32.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 25 | $6,525 | $2,428 | 37.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 18 | 18 | $3,816 | $1,976 | 51.8% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 24 | 24 | $5,808 | $1,707 | 29.4% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 15 | 15 | $4,530 | $1,496 | 33.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 31 | 31 | $3,968 | $1,353 | 34.1% |
About Dr. Michael Jacoby, MD
Dr. Michael Jacoby, MD is a Neurology healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346354198.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Jacoby, MD has received a total of $247,801 in payments from pharmaceutical and medical device companies, with $23,099 received in 2024. These payments were reported across 500 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($221,925).
As a Medicare-enrolled provider, Jacoby has provided services to 2,605 Medicare beneficiaries, totaling 3,233 services with total Medicare billing of $220,846. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Des Moines, IA
- Active Since 08/18/2006
- Last Updated 03/17/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1346354198
Products in Payments
- UBRELVY (Drug) $85,879
- QULIPTA (Drug) $45,531
- Aimovig (Biological) $43,745
- REYVOW (Drug) $22,814
- TROKENDI XR (Drug) $19,572
- VYEPTI (Biological) $9,724
- NURTEC ODT (Drug) $8,612
- EMGALITY (Drug) $7,702
- GILENYA (Drug) $355.32
- APTIOM (Drug) $183.92
- Activase (Biological) $149.51
- AUBAGIO (Drug) $133.09
- REXULTI (Drug) $122.95
- Briviact (Drug) $121.22
- BOTOX (Biological) $119.21
- AJOVY (Drug) $107.67
- KESIMPTA (Drug) $104.66
- ZEPOSIA (Drug) $103.67
- AIMOVIG (Biological) $95.21
- Mavenclad (Biological) $79.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Des Moines
Bruce Hughes, Md, MD
Neurology — Payments: $2.3M
Neurology $2.3M
Lynn Rankin, Md, MD
Neurology — Payments: $222,800
Neurology $222,800
Paul Babikian, Md, MD
Neurology — Payments: $162,701
Neurology $162,701
Wendy Zadeh, Md, MD
Neurology — Payments: $138,438
Neurology $138,438
Mark Puricelli, Do, DO
Neurology — Payments: $70,851
Neurology $70,851
Keith Kohout, Do, DO
Neurology — Payments: $53,823
Neurology $53,823